Tufton Capital Management’s Thermo Fisher Scientific TMO Stock Holding History

Tufton Capital Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-450	Closed	-$300K	–	132
2021 Q4	$300K	Hold	450	–	–	0.05%	117
2021 Q3	$257K	Hold	450	–	–	0.04%	113
2021 Q2	$227K	Hold	450	–	–	0.04%	120
2021 Q1	$205K	Buy	+450	New	+$215K	0.04%	124
2020 Q4	–	Sell	-500	Closed	-$220K	–	125
2020 Q3	$220K	Buy	+500	New	+$207K	0.05%	112
2020 Q1	–	Sell	-790	Closed	-$256K	–	118
2019 Q4	$256K	Hold	790	–	–	0.05%	107
2019 Q3	$230K	Hold	790	–	–	0.05%	114
2019 Q2	$232K	Sell	790 -60	-7%	-$16.5K	0.05%	118
2019 Q1	$232K	Buy	+850	New	+$212K	0.05%	114
2018 Q4	–	Sell	-850	Closed	-$207K	–	123
2018 Q3	$207K	Buy	+850	New	+$196K	0.04%	118
2018 Q2	–	Sell	-1,500	Closed	-$309K	–	123
2018 Q1	$309K	Hold	1,500	–	–	0.06%	106
2017 Q4	$285K	Hold	1,500	–	–	0.05%	112
2017 Q3	$284K	Hold	1,500	–	–	0.06%	109
2017 Q2	$262K	Sell	1,500 -15	-1%	-$2.52K	0.05%	104
2017 Q1	$233K	Buy	+1,515	New	+$232K	0.05%	111

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tufton Capital Management's TMO Position: Q1 2022 in Review

Tufton Capital Management sold out of Thermo Fisher Scientific (TMO) in Q1 2022, closing a stake of 450 shares — an estimated $300K sold.

Tufton Capital Management first reported a position in TMO in Q1 2017 and held it in 15 quarters. The position peaked at $309K in Q1 2018. 2,314 funds tracked by Wall St. Rank hold TMO as of Q1 2022.

Tufton Capital Management reported no remaining Thermo Fisher Scientific position as of Q1 2022 after selling out during the quarter.
Tufton Capital Management sold 450 Thermo Fisher Scientific shares in Q1 2022, an estimated $300K.
Tufton Capital Management first reported a position in Thermo Fisher Scientific in Q1 2017 and held it in 15 quarters.
Tufton Capital Management's Thermo Fisher Scientific position peaked at $309K in Q1 2018.
2,314 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2022.

Based on Tufton Capital Management's 13F filing for Q1 2022, filed 25 Apr 2022.